Lupin gains on acquiring 100% equity stake in Biocom

03 Jul 2015 Evaluate

Lupin is currently trading at Rs. 1910.05, up by 40.35 points or 2.16% from its previous closing of Rs. 1869.70 on the BSE.

The scrip opened at Rs. 1900.00 and has touched a high and low of Rs. 1913.70 and Rs. 1894.00 respectively. So far 7,899 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2112.00 on 08-Apr-2015 and a 52 week low of Rs. 1012.20 on 10-Jul-2014.

Last one week high and low of the scrip stood at Rs. 1918.20 and Rs. 1801.80 respectively. The current market cap of the company is Rs. 85,694.00 crore.

The promoters holding in the company stood at 46.63% while Institutions and Non-Institutions held 43.36% and 10.01% respectively.

Lupin has acquired 100% equity stake in ZAO ‘Biocom’ in Russia subject to certain closing conditions. The acquisition marks Lupin’s foray into the Russian pharmaceutical market which recorded RUB 765 billion in sales, placing it as one of the Top 10 pharmaceutical markets in the world in 2014 (IMS Health).

Established in 1991, Biocom is a fast growing generic pharmaceutical company with a major focus on therapies such as cardiovascular, central nervous system and antimicrobials for systemic use and also does contract manufacturing and secondary packaging.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products.


Lupin Share Price

2109.70 20.05 (0.96%)
17-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.95
Dr. Reddys Lab 1271.00
Cipla 1497.45
Zydus Lifesciences 917.85
Lupin 2109.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×